Nivolumab-induced bullous pemphigoid managed without drug withdrawal

Nivolumab-induced bullous pemphigoid managed without drug withdrawal

The widespread use of anti-programmed cell death receptor-1 (PD-1) agents has shed light to unusual immune-related adverse effects, especially affecting the skin. We report a case of bullous pemphigoid secondary to nivolumab therapy for metastatic renal carcinoma with a previously unreported complet...

Full description

Bibliographic Details
Main Authors: Mónica Munera-Campos, Adrià Plana-Pla, Noelia Rivera, Aram Boada, Carlos Ferrándiz
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Indian Journal of Dermatology
Subjects:
anti-programmed cell death receptor-1
bullous pemphigoid
nivolumab
renal carcinoma
topical treatment
Online Access:http://www.e-ijd.org/article.asp?issn=0019-5154;year=2020;volume=65;issue=3;spage=214;epage=216;aulast=Munera-Campos

Internet

http://www.e-ijd.org/article.asp?issn=0019-5154;year=2020;volume=65;issue=3;spage=214;epage=216;aulast=Munera-Campos

Similar Items